COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO
18/01/2018
FIT Biotech Oy Company release January 18, 2018 at 4.05 pm EET FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO The Board of Directors of FIT Biotech Oy (the "Company") has appointed Vice Chairman [...]
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting
18/01/2018
ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
Lexington Completes IRB Submission in Preparation for Clinical Study
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce it [...]
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
18/01/2018
BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical [...]
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center
18/01/2018
COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the Vilacto Bio Skincare Knowledge Center, an online resource that will gather [...]
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
18/01/2018
Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of [...]
Canada House Wellness Group Update on Abba Medix Grow Progress
18/01/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“ [...]
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results
18/01/2018
SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Celsion Corporation Provides Corporate Update and 2018 Outlook
18/01/2018
Company Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee’s Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% [...]
Radient Technologies Inc. Announces Key Management Appointment to RTI Global Health and Wellness Solutions
18/01/2018
EDMONTON, Alberta, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Corporation”) (TSX-V: RTI ) is pleased to announce the appointment of Dr. Marilena Radoiu to a key management role in its [...]
Argos Announces One-for-Twenty Reverse Stock Split
18/01/2018
DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes
18/01/2018
BASKING RIDGE, N.J. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency
18/01/2018
BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
DiaMedica Letter to Shareholders
18/01/2018
MINNEAPOLIS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ”) (TSX VENTURE:DMA) (OTCQB:DMCAF), provides corporate update. As we enter into 2018, we wanted to thank you, our shareholders, for [...]
REPEAT: Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce the closing of its [...]
Loop Industries Announces Strategic Initiative to Support evian’s Commitment to Adopt a Circular Approach to Plastic Usage
18/01/2018
MONTREAL, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) (the “Company” or “Loop”), a leader in the sustainable plastic revolution, today announced a strategic initiative with evian® as part of [...]
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
18/01/2018
DUBLIN, Ireland and TREVOSE, Pa., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
The Joint Corp. Opens 400th Clinic
18/01/2018
SCOTTSDALE, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, reached 400 open clinics systemwide in January, 2018, having [...]
Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development
18/01/2018
HALIFAX, Nova Scotia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has appointed Joseph Sullivan to the newly created [...]

Pages